Thompson Siegel & Walmsley’s NCI, Inc. NCIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-2,100
Closed -$44K 899
2017
Q2
$44K Hold
2,100
﹤0.01% 550
2017
Q1
$32K Hold
2,100
﹤0.01% 594
2016
Q4
$29K Buy
+2,100
New +$26.5K ﹤0.01% 554

Thompson Siegel & Walmsley's NCIT Position: Q3 2017 in Review

Thompson Siegel & Walmsley sold out of NCI, Inc. (NCIT) in Q3 2017, closing a stake of 2,100 shares — an estimated $44K sold.

Thompson Siegel & Walmsley first reported a position in NCIT in Q4 2016 and held it in 3 quarters. The position peaked at $44K in Q2 2017. 0 funds tracked by Wall St. Rank hold NCIT as of Q3 2017.

  • Thompson Siegel & Walmsley reported no remaining NCI, Inc. position as of Q3 2017 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 2,100 NCI, Inc. shares in Q3 2017, an estimated $44K.
  • Thompson Siegel & Walmsley first reported a position in NCI, Inc. in Q4 2016 and held it in 3 quarters.
  • Thompson Siegel & Walmsley's NCI, Inc. position peaked at $44K in Q2 2017.
  • 0 funds tracked by Wall St. Rank held NCI, Inc. as of Q3 2017.

Based on Thompson Siegel & Walmsley's 13F filing for Q3 2017, filed 8 Nov 2017.